Warning: Creating default object from empty value in /home4/sspccco/public_html/pharmafacts.com/plugins/system/J2top.php on line 78
S7B - PharmaFacts
If you don't find what you're looking for, please let us know.


Guidances - ICH Guidances
Revised: The Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization:  (QT Interval Prolongation) By Human Pharmaceuticals:

The Guideline reached Step 4 of the ICH process on 12 May 2005.  This guideline describes a non-clinical testing strategy for assessing the potential of a test substance to delay ventricular repolarization.  This guideline includes information concerning non-clinical assays and integrated risk assessments.